BIO.News Newsletter

It’s Halloween—and we have scary news about not one, not two, but three viruses circulating in the U.S. Plus, more takeaways from BIO’s Patient and Health Advocacy Summit on the need to center patients, what’s ahead in state legislatures, and engaging with CMS. (710 words, 3 minutes, 33 seconds)

Every member of the Council of State Bioscience Associations (CSBA) joined a letter expressing concerns about expanding the COVID IP waiver, and Mexico’s Deputy Ag Minister confirmed the corn ban is happening. Plus, three takeaways from Day 1 of the Patient and Health Advocacy Summit and how to follow the conversations today. (894 words, 4 minutes, 28 seconds)

We’re at the BIO Patient and Health Advocacy Summit in Washington, D.C., this week, where our team will bring you news and highlights right here and at Bio.News—keep reading to learn how you can follow along and why the patient voice matters, plus, some almost positive news on climate. (543 words, 2 minutes, 42 seconds)

Two reports you need to know about today. First, a new report released by BIO and CSBA with TEConomy finds the U.S. biotech industry is a major economic driver in all 50 states and explores why investment is booming. Second, WHO released the first-ever list of fungal priority pathogens, with 19 fungi we need to pay attention to. (552 words, 2 minutes, 45 seconds)

BIO joined with the international industry to offer a practical solution for global vaccine access that doesn’t hurt innovation. Also, it’s not even Halloween and we’re already excited for Thanksgiving—or we would be, if the price of turkey wasn’t skyrocketing. Biotech has a solution. (596 words, 2 minutes, 58 seconds)

More congressional leaders are speaking out against expanding the waiver of IP protections for COVID technology. Plus, USAID’s Samantha Power visited BIO member Corteva and spoke about the need for innovation to “break the cycle” of food crises. (621 words, 3 minutes, 6 seconds)

A busy Friday, with a look at a big boost for SAF, why you should get an Omicron booster, and a lot more news. (756 words, 3 minutes, 46 seconds)

A busy week for the bioeconomy in D.C., with President Biden launching the National Biodefense Strategy and bipartisan U.S. Senators expressing serious concerns about the expansion of the WTO’s COVID-19 IP waiver. Also, it’s World CRISPR Day—we look at recent developments. (856 words, 4 minutes, 16 seconds)

BIO member Ginkgo Bioworks has partnered with the federal government to detect potential bioweapons faster than ever before—thanks to synbio. Plus, the CDC says flu season is already here—and it’s time to catch up on your vaccines. (659 words, 3 minutes, 17 seconds)

Today’s new episode of the I am BIO Podcast features two patient advocates who have played a role in bringing potential treatments to rare disease patients. We recap Bayer’s event yesterday exploring how biotech can help farmers reduce their footprint AND increase their yields. (729 words, 3 minutes, 38 seconds)